572 related articles for article (PubMed ID: 36982568)
1. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
Pang Y; Lu T; Xu-Monette ZY; Young KH
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982568
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.
Li Z; Zhang H
Cell Mol Life Sci; 2016 Jan; 73(2):377-92. PubMed ID: 26499846
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming as a feast for virus replication.
Polcicova K; Badurova L; Tomaskova J
Acta Virol; 2020; 64(2):201-215. PubMed ID: 32551788
[TBL] [Abstract][Full Text] [Related]
4. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of Metabolism in Kidney Cancer.
Wettersten HI
Semin Nephrol; 2020 Jan; 40(1):2-13. PubMed ID: 32130963
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial and metabolic alterations in cancer cells.
Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V
Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Reprogramming of the Glucose Metabolic Pathways by the Chromatin Effectors During Cancer.
Mondal P; Tiwary N; Sengupta A; Dhang S; Roy S; Das C
Subcell Biochem; 2022; 100():269-336. PubMed ID: 36301498
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.
Balakrishnan K; Ganesan K
Funct Integr Genomics; 2020 Nov; 20(6):813-824. PubMed ID: 32949316
[TBL] [Abstract][Full Text] [Related]
9. Roles of microRNAs in metabolic reprogramming of breast cancer.
Feng F; Yu Q; Zhang F
J Pak Med Assoc; 2022 Feb; 72(2):312-316. PubMed ID: 35320184
[TBL] [Abstract][Full Text] [Related]
10. Glutamine Is Required for M1-like Polarization of Macrophages in Response to Mycobacterium tuberculosis Infection.
Jiang Q; Qiu Y; Kurland IJ; Drlica K; Subbian S; Tyagi S; Shi L
mBio; 2022 Aug; 13(4):e0127422. PubMed ID: 35762591
[TBL] [Abstract][Full Text] [Related]
11. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells.
Yang Y; Huangfu L; Li H; Yang D
Int J Hyperthermia; 2023; 40(1):2270654. PubMed ID: 37871910
[TBL] [Abstract][Full Text] [Related]
12. 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.
Chiasserini D; Davidescu M; Orvietani PL; Susta F; Macchioni L; Petricciuolo M; Castigli E; Roberti R; Binaglia L; Corazzi L
J Proteomics; 2017 Jan; 152():329-338. PubMed ID: 27890797
[TBL] [Abstract][Full Text] [Related]
13. How glucose, glutamine and fatty acid metabolism shape blood and lymph vessel development.
Teuwen LA; Geldhof V; Carmeliet P
Dev Biol; 2019 Mar; 447(1):90-102. PubMed ID: 29224892
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment.
Adhikari S; Guha D; Mohan C; Mukherjee S; Tyler JK; Das C
Subcell Biochem; 2022; 100():3-65. PubMed ID: 36301490
[TBL] [Abstract][Full Text] [Related]
15. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
[TBL] [Abstract][Full Text] [Related]
16. The role of metabolic reprogramming in pancreatic cancer chemoresistance.
Liu C; Li C; Liu Y
Front Pharmacol; 2022; 13():1108776. PubMed ID: 36699061
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.
Shang RZ; Qu SB; Wang DS
World J Gastroenterol; 2016 Dec; 22(45):9933-9943. PubMed ID: 28018100
[TBL] [Abstract][Full Text] [Related]
18. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
19. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
20. Metabolic targeting of cancers: from molecular mechanisms to therapeutic strategies.
Sheng H; Niu B; Sun H
Curr Med Chem; 2009; 16(13):1561-87. PubMed ID: 19442134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
